Kobo Biotech

{
  "main_header": {
    "sid": 487832,
    "name": "Kobo Biotech",
    "stock_name": "Kobo Biotech",
    "full_name": "Kobo Biotech Ltd",
    "name_url": "stocks-analysis/kobo-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "3.00",
    "chg": 0.12,
    "chgp": "4.17%",
    "dir": 1,
    "prev_price": "2.88",
    "mcapval": "7.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531541,
    "symbol": "",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE881A01015",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "10.71 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kobo-biotech-487832-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Kobo Biotech Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kobo-biotech-ltd-fallingrising-3771705",
        "imagepath": "",
        "date": "2025-12-27 00:41:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Downtrend Against Market Benchmarks</strong></p>\n<p>Kobo Biotech’s recent price movement reflects a broader trend of sustained decline. Over the past week, the stock has dropped by 5.46%, sharply contrasting with the Sensex’s modest gain of 0.13% during the same period. The disparity becomes even more pronounced over longer horizons: the stock has lost more than half its value in the last year, registering a negative return of 50.66%, while the Sensex has advanced by 8.37%. Over three and five years, Kobo Biotech’s performance remains deeply disappointing, with losses exceeding 46% and 74% respectively, compared to the Sensex’s robust gains of over 40% and 81% in those periods.</p>\n<p><strong>Technical Indicators Signal Weak Momentum</strong></p>\n<p>From a technical perspective, K..."
      },
      {
        "title": "Kobo Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kobo-biotech-ltd-is-rated-strong-sell-3771561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KoboBiotechLtd_mojoScore_3771561.png",
        "date": "2025-12-26 21:51:26",
        "description": "Kobo Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 03 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Kobo Biotech Sees Revision in Market Evaluation Amidst Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kobo-biotech-downgraded-to-strong-sell-amid-weak-fundamentals-and-risky-valuation-3756225",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KoboBiotech_mojoScore_3756225.png",
        "date": "2025-12-11 10:10:04",
        "description": "Kobo Biotech, a microcap player in the Commodity Chemicals sector, has undergone a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The recent assessment highlights shifts across key analytical parameters, signalling a cautious outlook for investors."
      },
      {
        "title": "Kobo Biotech Falls to 52-Week Low of Rs.2.06 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kobo-biotech-stock-falls-to-52-week-low-of-rs206-amidst-weak-fundamentals-3756156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KoboBiotech_priceRelatedfactors_3756156.png",
        "date": "2025-12-11 09:50:49",
        "description": "Kobo Biotech, a player in the commodity chemicals sector, has reached a new 52-week low of Rs.2.06, marking a significant decline in its stock price amid ongoing challenges reflected in its financial and market performance."
      },
      {
        "title": "Kobo Biotech Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kobo-biotech-faces-intense-selling-pressure-amid-sharp-declines-3748493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KoboBiotech_only_sellers_3748493.png",
        "date": "2025-12-05 10:00:26",
        "description": "Kobo Biotech Ltd, a player in the Commodity Chemicals sector, is currently experiencing severe selling pressure, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. The stock has recorded consecutive declines over the past three days, signalling distress selling and heightened market caution."
      },
      {
        "title": "Kobo Biotech Sees Unprecedented Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kobo-biotech-hits-upper-circuit-amidst-unprecedented-buying-interest-3748106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KoboBiotech_only_buyers_3748106.png",
        "date": "2025-12-05 09:40:32",
        "description": "Kobo Biotech Ltd has attracted extraordinary buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a multi-day circuit scenario, underscoring a significant shift in trading dynamics for the commodity chemicals company."
      },
      {
        "title": "Kobo Biotech Faces Intense Selling Pressure Amid Consecutive Losses and Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kobo-biotech-faces-severe-selling-pressure-as-stock-hits-lower-circuit-3746493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KoboBiotech_only_sellers_3746493.png",
        "date": "2025-12-04 10:35:47",
        "description": "Kobo Biotech Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.94% today and showing no buying interest. The commodity chemicals company continues to underperform the broader market, reflecting distress selling signals and a challenging trading environment."
      }
    ],
    "total": 179,
    "sid": "487832",
    "stock_news_url": "https://www.marketsmojo.com/news/kobo-biotech-487832"
  },
  "announcements": [
    {
      "caption": "Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors",
      "datetime": "30-Oct-2025",
      "details": "Outcome of the 7th CoC Meeting held on 06-05-2025",
      "source": "BSE"
    },
    {
      "caption": "Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors",
      "datetime": "30-Oct-2025",
      "details": "The 15th Meeting of Committee of Creditors of Kobo Biotech Limited was held on Wednesday1st October2025 at 03:45 p.m. at 215 Laxmi Plaza Laxmi Industrial Estate New Link Road Andheri West Mumbai 400053 through video conferencing.",
      "source": "BSE"
    },
    {
      "caption": "Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors",
      "datetime": "30-Oct-2025",
      "details": "Outcome of the 4th CoC Meeting held on 13-01-2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kobo Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 21 Sep 12",
          "dt": "2012-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Kobo Biotech Ltd falling/rising?

2025-12-27 00:41:11

Persistent Downtrend Against Market Benchmarks

Kobo Biotech’s recent price movement reflects a broader trend of sustained decline. Over the past week, the stock has dropped by 5.46%, sharply contrasting with the Sensex’s modest gain of 0.13% during the same period. The disparity becomes even more pronounced over longer horizons: the stock has lost more than half its value in the last year, registering a negative return of 50.66%, while the Sensex has advanced by 8.37%. Over three and five years, Kobo Biotech’s performance remains deeply disappointing, with losses exceeding 46% and 74% respectively, compared to the Sensex’s robust gains of over 40% and 81% in those periods.

Technical Indicators Signal Weak Momentum

From a technical perspective, K...

Read full news article

Kobo Biotech Ltd is Rated Strong Sell

2025-12-26 21:51:26

Kobo Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 03 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Kobo Biotech Sees Revision in Market Evaluation Amidst Challenging Financials

2025-12-11 10:10:04

Kobo Biotech, a microcap player in the Commodity Chemicals sector, has undergone a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The recent assessment highlights shifts across key analytical parameters, signalling a cautious outlook for investors.

Read full news article

Kobo Biotech Falls to 52-Week Low of Rs.2.06 Amidst Continued Underperformance

2025-12-11 09:50:49

Kobo Biotech, a player in the commodity chemicals sector, has reached a new 52-week low of Rs.2.06, marking a significant decline in its stock price amid ongoing challenges reflected in its financial and market performance.

Read full news article

Kobo Biotech Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-05 10:00:26

Kobo Biotech Ltd, a player in the Commodity Chemicals sector, is currently experiencing severe selling pressure, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. The stock has recorded consecutive declines over the past three days, signalling distress selling and heightened market caution.

Read full news article

Kobo Biotech Sees Unprecedented Buying Interest Amid Upper Circuit Scenario

2025-12-05 09:40:32

Kobo Biotech Ltd has attracted extraordinary buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a multi-day circuit scenario, underscoring a significant shift in trading dynamics for the commodity chemicals company.

Read full news article

Kobo Biotech Faces Intense Selling Pressure Amid Consecutive Losses and Market Underperformance

2025-12-04 10:35:47

Kobo Biotech Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.94% today and showing no buying interest. The commodity chemicals company continues to underperform the broader market, reflecting distress selling signals and a challenging trading environment.

Read full news article

View All News